Megh Milind Panandikar

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 1 saleSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (2 ops.)

€6,331

▼ Sales (1 ops.)

€37k

Latest filing published 08 Aug 2025 for Indoco Remedies Limited, €37k.

Filing timeline

BuySale

Megh Milind Panandikar

Megh Milind Panandikar: trading record in brief

Megh Milind Panandikar appears in our data through filings on Indoco Remedies Limited shares, published by SEBI (PIT + SAST). We count 3 filings; the first trade dates from 7 June 2023 and the latest from 7 August 2025.

The open-market side counts 2 purchases for €6,331 alongside 1 sale for €37k. Sales outweigh purchases by €31k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2025 alone, the filings show no purchases and 1 sale.

The newest entry dates from 8 August 2025: an open-market sale of €37k, in Indoco Remedies Limited. The last insider purchase was made public on 4 June 2024, 872 days ago. Typically, a trade is published a median of 1 day after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.